Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[EX Q]: Paragraph: Use of such pills, which include Sanofi SA's Ambien and other similar drugs, was significantly higher for those in their 50s as well as age 80 and older, according to the findings from the Centers for Disease Control and Prevention. Overall about 8.6 million people, or 4 percent of U.S. adults reported recently using sleep medication, CDC's National Center for Health Statistics said in a report. But data showed higher use among middle-aged adults ages 50 to 59 and the elderly. Six percent of those ages 50 to 59 said they had taken a prescription sleep pill in the last 30 days, and 7 percent of those age 80 and older reported such use. In between, the numbers dip slightly below 6 percent for those in their 60s and 70s. In comparison, just 2 percent of those aged 20-39 said they had recently taken a sleep aid. CDC researcher Yinong Chong said people in their 50s could have trouble sleeping because of work and family stress. "It gives the picture of a sandwiched group who has family, not only children but also probably elderly parents but still you're likely to be in the workforce, so you get squeezed at both ends in terms of family responsibility and job responsibility," she said. Sleep may improve when people retire before potential chronic health problems kick in and begin interfering with sleep, Chong said, adding more study is needed. The data also showed that 5 percent of women surveyed said they had recently taken a sleep aid compared to about 3 percent of male respondents, according to CDC's report. Chong said it was not clear why women were more likely to use the drugs. While previous data have tracked prescriptions dispensed for sleep aids, the CDC said its study is the first based on a survey of actual use of such drugs. Researchers for the Atlanta-based health agency's National Center for Health Statistics questioned a sampling of adults age 20 and older about whether they had used prescription sleep aids within the last 30 days and asked participants to show interviewers the prescription medication. "You get how many people are actually using them," Chong said in an interview, noting that prescription data could include multiple prescriptions for one patient or prescriptions that are never filled or even used. "This is actual use." Prescription sleep aids have become somewhat controversial because their effect can linger even after some patients wake up. The U.S. Food and Drug Administration has begun taking a closer look at sleep drugs, ordering lower-doses for Ambien and similar pills amid concerns that their active ingredient remained in patients' blood the following morning at levels high enough to make driving and other activities dangerous. And just last month, the FDA rejected an experimental sleep drug from Merck & Co Inc, saying the proposed doses were not safe but that a lower-dose version might be acceptable. Not surprisingly, respondents to CDC's study who said they slept five hours or less each night or those diagnosed with a sleep disorder were more likely to report using prescription aids. Additionally, more whites and people with higher levels of education also reported greater use, the agency said. Socioeconomic factors are likely behind those numbers, Chong said, since patients must be able to afford a doctor's care and the medication. According to prescription data from IMS Health, Ambien and other versions of the drug zolpidem was ranked 15th among the most dispensed medications in the United States. Claim: Use of sleeping pills highest among older Americans: CDC.
[EX A]: Older U.S. adults, particularly women, are more likely to use prescription sleep medications to try to get the minimum seven hours of sleep experts generally recommend, U.S. data released on Thursday showed.

[EX Q]: Paragraph: "The water affects everyone," she said, which is why she believes her job is so important. Reese is studying public health and environmental health at East Carolina University in North Carolina. She will be an intern for the East Shore department, working on the Connecticut shoreline until the end of July. Reese spends her Tuesday mornings driving around to all the public and private natural swimming areas in Branford, North Branford and East Haven, collecting water samples and putting them on ice in her purple cooler. The samples are then collected by state Department of Public Health couriers and brought to the state lab in Rocky Hill for testing. Water quality testing has always been a priority for the East Shore department every summer, but this year, Alex Cinotti, the assistant director of health, has something he's trying to prove. Every year, from Memorial Day to Labor Day, the department collects weekly water samples from 12 water bodies used for swimming, both freshwater and saltwater, to ensure bacteria levels are low enough for public safety. Samples are collected and tested once a week, and as long as bacteria levels fall below state-determined risk levels, the beaches and other water bodies remain open. This year, however, Cinotti would like to take the sampling a step further to show a direct correlation between rainfall and elevated bacteria levels, he said, as rain will often wash contaminants into public waters and cause bacteria levels to rise. "This is our opportunity to take samples and establish a pattern," Cinotti said. "Bacteria is bacteria and we consider it pathogenic." As such, in addition to the weekly sampling of water, Cinotti said that the department is collecting samples after heavy rains to see if bacteria levels rise after rainfall. This kind of analysis could not be done last summer, Cinotti said, because there were few rain events due to the drought. On the state level, the Department of Energy and Environmental Protection will close public beaches after a significant amount of rainfall, in anticipation of potentially higher bacteria levels. Scott Szalkiewicz, a health program supervisor for the state Health Department, told the Register last summer that because samples take 24 hours to process, it's helpful to be able to close beaches before test results come in when officials believe bacteria levels will be high based on the amount of rain and visual indicators. The East Shore District Health Department serves Branford, North Branford and East Haven. The 12 bathing waters surveyed each week include the east and west East Haven beaches, the Clark Avenue beach, Branford Point, Stony Creek, Hotchkiss Grove, Turtle Bay, Sunrise Cove, Lanphier Cove, Cedar Lake, Linsley Lake and Clear Lake. According to water quality records from the East Shore District Health Department in 2016, there was only one time when bacteria levels reached a level at which one of the beaches had to close. Sunrise Cove reached a level of 1,000 colonies of bacteria in the sample of 100 milliliters of water on Aug. 2, 2016, according to the records. Cinotti said that the safe levels for salt water are 104 colonies of bacteria per 100 milliliters of water and 235 colonies for fresh water per 100 milliliters of water. Some things that cause heightened bacteria levels include wild animal and dog feces, sewer overflows and leaks, Cinotti said. Rain may wash contaminants such as sewer overflows, nitrogen-rich pollutants and goose and dog feces into the Sound and other bathing water bodies. Potential health risks from swimming in water with high levels of bacteria include possible infections to open wounds and gastrointestinal illness when water is accidentally swallowed, Cinotti said. He added that it's possible swimmers could contract eye- or ear-related illnesses from high levels of bacteria. "We really need to protect children," Cinotti said. "They are more vulnerable than adults." ___ Online: http://bit.ly/2rFTp4s ___ Information from: New Haven Register, http://www.nhregister.com Claim: Officials study link between rain and bacteria in water.
[EX A]: For Kellyn Reese, waking up on Tuesday mornings and going to the beach because it's her job is a nice perk of being a summer intern at the East Shore District Health Department.

[EX Q]: Paragraph: The article does not offer any cost information. The article offers general statements about the "dramatic" and rapid effects of UA from Allergan researchers, but does not provide any numerical context or offer summaries of research with that information. The article notes the side effects of UA and potentially two other similar drugs in the pipeline. The main concern about these agents is the effects they may have on the endometrium (uterine lining) over time. The evidence is generally AWOL. A personal testimonial from a celebrity with fibroids does not stand in for evidence one expects to see from a clinical trial or trials. No mongering here. The article quotes one outside expert whose comments focused on the use of an injectable alternative to the oral drug, and the downsides of this alternative. But it also has a comment from Allergan's researcher noting that longer-time follow up is needed for UA. These source's commercial relationships are appropriately disclosed. [Editor's note: Following publication of this review, we learned that Allergan provides financial support to the White Dress Project. The story would have done well to acknowledge this relationship.] The article mentions some alternative treatments in detail. One strength of the article is that it prominently points out that many women with fibroids who have no symptoms do not require treatment of any kind. The article notes the new drug could be available in the US next year. The drug is already available in the US for another indication but is packaged in doses that are much larger than those used for fibroid treatments. The article makes clear that the advantage of the new drug is that it is an oral medication, and is taken for a limited time. However, ulipristal is not the first oral medication. There are some older oral hormonal medications, including pills in some cases, that have been tried. GnRH agonists (delivered by injection or nasal spray) such as Lupron have been used in limited situations to treat fibroids, but their use is limited by side effects related to medically induced menopause. The story includes comments from two experts and it appears as though the second one had no involvement with the study. Claim: New Treatment for Fibroids Without Surgery
[EX A]:
This Wall Street Journal article describes the advent of a neworal medication,uliprital acetate, or UA, to treat severe bleeding and other symptoms associated with uterine fibroids. Although the article does a goodjob of putting Allergan's new oral drug in context and noting alternative treatments (hysterectomy, myomectomy) and similar drugs in the pipeline, it offers no numerical context that women and their physicians might use to evaluate the relative benefits and risks of the newer treatment. As the article aptly points out, uterine fibroids are a source of significant pain, bleeding, anemia, infertility and disability in tens of millions of women, most of them in their childbearing years. The symptoms and complications can seriously interfere with everyday life. The causes of uterine fibroid have been intensively studied over the past decade. More is understood now about the important role of genetic and hormonal factors in development of fibroids. For decades, the common treatment for uterine fibroids has been their surgical removal (where they often grow back) or hysterectomy. But some newer less invasive procedures such as uterine artery embolization and MRI-guided focused ultrasound have provided other treatment options. Use of medication has been limited to hormone affecting medications that can cause drug-induced menopause. Thus, a pill like UA already available in Europe adds a treatment option that may be helpful. What is missing from the article are data documenting and explaining what proportion and kind of patient group the drug would most and least benefit; and other data to help women determine if UA is a good option for them.